Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterActive in the last 2 years

David L. Morse

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6006-7528; OpenAlex author ID A5027944218; NIH RePORTER profile ID 9855573. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
1
Labs led
1
Collaborators
4
Papers, trials and grants by year

2011: 1 paper, 1 grant · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Intraoperative Guidance of Pancreatic Cancer Resection Using a Toll-like Receptor 2-Targeted Fluorescence Molecular Imaging Agent. Last author DOI 10.1158/2767-9764.crc-24-0244↗
  2. Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapy. Co-author DOI 10.1021/jm301002f↗
  3. Development of an orthotopic human pancreatic cancer xenograft model using ultrasound guided injection of cells. Last author DOI 10.1371/journal.pone.0020330↗

Grants 1

  1. Targeting Pancreatic Cancer R01CA123547↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Amanda Shanks Huynh · 3 shared papers, 2011–2024 · strength 0.25
  2. Josef Vágner · 2 shared papers, 2012–2024 · strength 0.22
  3. Barbara Ann Centeno · 1 shared paper, 2024 · strength 0.18
  4. Robert J. Gillies · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.